Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial

Overview of attention for article published in The Lancet, January 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

Mentioned by

news: 80 news outlets
blogs: 9 blogs
policy: 1 policy source
twitter: 217 X users
patent: 1 patent

facebook: 10 Facebook pages
wikipedia: 2 Wikipedia pages
reddit: 6 Redditors
f1000: 1 research highlight platform
video: 1 YouTube creator

Citations

dimensions_citation: 671 Dimensions

Readers on

mendeley: 881 Mendeley
citeulike: 1 CiteULike

Summary News Blogs Policy documents X Patents Facebook Wikipedia Reddit Research highlights YouTube Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

PHOSPHOLIPID COMPOSITIONS FOR DELIVERY OF THERAPEUTIC COMPOUNDS

Application WO-2024095090-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.